Investor directory

Medicxi

VC fundLondon, United Kingdommedicxi.comLinkedIn

Medicxi specializes in biotechnology investments with a focus on innovative therapeutic solutions.

What they invest in

Geographies

EUUS

The facts

Founded
2016

Portfolio companies

More portfolio companies

Phathom Pharmaceuticals (NAS: PHAT)ProfoundBioCurevo VaccineD3 BioViceBioVaxcyte (NAS: PCVX)Rivus PharmaceuticalsAura Biosciences (NAS: AURA)Breakpoint TherapeuticsAldena TherpeuticsXenikosCheckmate PharmaceuticalsLeviceptAltesa BioSciencesFore BiotherapeuticsAlys PharmaceuticalsVaderis TherapeuticsDiasomeSynthorxCritical PressureVersanis BioApcinteXDivide & ConquerSydnexis

and 25 more

Recent rounds

  • Vaderis Therapeutics

    USD 152 millionSeries BBiotech & Pharma

    TCGXleadLife SciencesleadGoldman SachsleadMedicxiOmega FundsPerceptive Advisors · +4 more in the source

    Switzerlandprnewswire.com

Rounds Medicxi took part in, as reported by the linked articles. See who else is investing right now.

Questions founders ask

Which stages does Medicxi invest in?
Medicxi invests at Growth, Series A, Series B and Seed.
Where is Medicxi based?
Medicxi is headquartered in London, United Kingdom.

Does Medicxi fit your round?

In 30 minutes you'll know which funds matter for your round.

Get a demo

Search investors like this in Claude — no account, no sign-in. Open in Claude

Are you Medicxi? Tell us what to correct and we will update it — or ask us to remove the entry.